33.90 -1.06 (-3.05%)
LLY
Stock Details
Last Trade:33.90 Change:-1.06 (-3.05%) Prev Close:34.96 Open: 34.71 Days Range:33.90 – 34.71 52 Week Range: 27.21 - 49.78 Volume:4493413 P/E: N/AEPS:-1.66
View AllRecent Alerts 07/03/09
Recent Alert on 06/22/09 at 5:05pm
Eli Lilly (LLY) Approves $0.49 Per Share Quarterly Dividend
Eli Lilly (LLY) Approves $0.49 Per Share Quarterly Dividend
Eli Lilly and Company (NYSE: LLY) declared a dividend for the third quarter of 2009 of $0.49 a share on outstanding common stock. This is the same dividend as was paid in the first and second quarters and maintains the annual indicated dividend rate... Read More
Recent Alert on 06/09/09 at 8:18am
Eli Lilly (LLY) Selects ICON plc (ICLR) to Manage Clinical Trial Site Set Up and Monitoring in Europe
Eli Lilly (LLY) Selects ICON plc (ICLR) to Manage Clinical Trial Site Set Up and Monitoring in Europe
Recent Alert on 06/08/09 at 5:36pm
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Recent Alert on 06/08/09 at 5:36pm
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
View AllRecent Press Releases
Press Release on 07/01/09 at 12:39pm
National BDPA and WorkplaceDiversity.com Announce Winners of the 2009 Best Companies for Blacks in Technology Award
National BDPA and WorkplaceDiversity.com Announce Winners of the 2009 Best Companies for Blacks in Technology Award
Press Release on 06/30/09 at 7:30am
Cellceutix Announces Dr. Emil Frei to be On Its Scientific Advisory Board Through June 30, 2010
Cellceutix Announces Dr. Emil Frei to be On Its Scientific Advisory Board Through June 30, 2010